Cargando…
Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
• Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown. • Pembrolizumab successfully treated a patient with metastatic SCC. • Patients on pembrolizumab should be monitored for immune-related adverse events.
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326349/ https://www.ncbi.nlm.nih.gov/pubmed/34368414 http://dx.doi.org/10.1016/j.gore.2021.100837 |